Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials
The DOI matches its Crossref record; 22 of the 23 references it cites were found in a registry or an index.
Abstract
Aim This article provides the first comprehensive meta-analysis of randomized clinical trials of medications for obesity.Method Based on stringent inclusionary criteria, a total of 108 studies were included in the final database. Outcomes are presented for comparisons of single and combination drugs to placebo and for comparisons of medications to one another.Result Overall, the medications studied produced medium effect sizes. Four drugs produced large effect sizes (ie d>0.80; amphetamine, benzphetamine, fenfluramine and sibutramine). The placebo-subtracted weight losses for single drugs vs placebo included in the meta-analysis never exceeded 4.0 kg. No drug, or class of drugs, demonstrated clear superiority as an obesity medication. Effects of methodological factors are also presented along with suggestions for future research.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a meta-analysis of phentermine monotherapy clinical trials, the placebo-corrected reduction in body weight with phentermine was less than 4 kg”
From Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022 (2022) · cites this paper as [49]
In the citing paper
“The pooled analysis showed that those treated with phentermine along with diet and lifestyle lost 3.6 kg more than patients treated with diet and lifestyle alone.”
From Obesity‐Related Hypertension: Pathogenesis, Cardiovascular Risk, and Treatment: A Position Paper of The Obesity Society and the American Society of Hypertension (2013) · cites this paper as [196]
Citations
Cites
Statistical Methods for Meta-Analysis
Wasserman, S., Hedges, L. V., & Olkin, I. (1988) · Journal of Educational Statistics · doi:10.2307/1164953 · Cited by 10,326
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795
Statistical Methods for Meta-Analysis.
Freeman, P. R., Hedges, L. V., & Olkin, I. (1986) · Biometrics · doi:10.2307/2531069 · Cited by 4,784
Lipsey, M. W., & Wilson, D. B. (1993) · American Psychologist · doi:10.1037/0003-066x.48.12.1181 · Cited by 2,033
Estimation of effect size from a series of independent experiments.
Hedges, L. V. (1982) · Psychological Bulletin · doi:10.1037//0033-2909.92.2.490 · Cited by 1,062
The Handbook of Research Synthesis
Hanka, R. (1994) · BMJ · doi:10.1136/bmj.309.6952.488a · Cited by 1,052
Haller, C. A., & Benowitz, N. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432502 · Cited by 956
Effect of sibutramine on weight maintenance after weight loss: a randomised trial
James, W. P. T., Astrup, A., Finer, N., Hilsted, J., Kopelman, P., Rössner, S., Saris, W. H. M., & Gaal, L. F. V. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03491-7 · Cited by 817
Phenylpropanolamine and the Risk of Hemorrhagic Stroke
Kernan, W. N., Viscoli, C. M., Brass, L. M., Broderick, J. P., Brott, T., Feldmann, E., Morgenstern, L. B., Wilterdink, J. L., & Horwitz, R. I. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432501 · Cited by 611
Research works printed but not linked: 3
- Scoville BA . Review of amphetamine like drugs by the Federal Drug Administration: clinical data and value judgments. In: G Bray (ed). Obesity in perspective, DHEW publication no. (NIH) 75–708. US Government Printing Office: Washington, DC 1973.
- Shadish, WR, Haddock, CK . Combining estimates of effect size. In: H Cooper, LV Hedges (eds). The handbook of research synthesis Russell Sage: New York 1994 261–281.
- National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) . Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity: the evidence report US Government Press: Washington DC 1998.
Cited by
Items 201–300 of 303
A review on the current drugs and new targets for obesity
Poojashree, M. J. (2020) · Journal of Applied Pharmaceutical Research · doi:10.18231/j.joapr.2019.v.8.i.1.002 · Cited by 3
Anti-Obesity Drugs for Obese Women Planning Pregnancy
Li, R., Lee, C. P., Lam, K. S. L., & Ho, P. C. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416045-3.00031-5 · Cited by 4
Dunican, K. C., Desilets, A. R., & DeBellis, R. J. (2007) · American Journal of Lifestyle Medicine · doi:10.1177/1559827607303256 · Cited by 3
Tsai, A. G., Raube, E., Conrad, J., Bessesen, D. H., & Rozwadowski, J. M. (2012) · Journal of Primary Care & Community Health · doi:10.1177/2150131912439893 · Cited by 3
Historical Drug Therapies in Obesity
Bashir, A., & Weaver, J. U. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-48559-3.00025-7 · Cited by 3
Clinical Management of the Metabolic Syndrome
(2007) · Springer eBooks · doi:10.1007/978-1-84628-911-8_6 · Cited by 3
Viñoles, C., Sosa, C., Meikle, A., & Abecia, J. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800872-0.00009-3 · Cited by 2
Es mortal, mas se puede prevenir y controlar
Cordero, R. R. Á. (2010) · Revista de la Facultad de Medicina UNAM · Cited by 2
The Role of Serotonin in Eating Behavior: Focus on 5-HT2C Receptors
Halford, J. C. G. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-941-3_17 · Cited by 2
Pharmacotherapy for Weight Loss
Lutz, T. A., & Asarian, L. (2017) · CRC Press eBooks · doi:10.1201/9781315120171-13 · Cited by 3
Palmer, K. D., & Apovian, C. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802928-2.00022-9 · Cited by 2
Meta-analysis of Change in Weight and Heart Rate for Phentermine in Obesity
Woo, Y., & Jeong, H. (2018) · Journal of Health Informatics and Statistics · doi:10.21032/jhis.2018.43.4.290 · Cited by 2
Sorrentino, M. J. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-502-6_2 · Cited by 3
Antiobesity drugs for obese women planning pregnancy
Li, R., Lam, K. S. L., & Ho, P. C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817921-5.00030-8 · Cited by 3
Mathus-Vliegen, E. M. H., Nikkel, D., & Brand, H. S. (2005) · PubMed · Cited by 2
Uchegbu, E. C., & Kopelman, P. G. (2004) · Elsevier eBooks · doi:10.1016/b0-12-226694-3/00237-4 · Cited by 2
Bray, G. A. (2005) · Humana Press eBooks · doi:10.1385/1-59259-865-x:241 · Cited by 1
Cardiovascular Risk in Obese Type 2 Diabetes Mellitus Patients
Román, G., Formiguera, X., & Hâncu, N. (2003) · Springer eBooks · doi:10.1007/978-3-642-59352-9_10 · Cited by 1
Diagnosis, Evaluation, and Medical Management of Obesity and Diabetes
Chan, J. L., & Mantzoros, C. S. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-453-1_16 · Cited by 1
Halpern, B., Daher, G., & Halpern, A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8684-8_41 · Cited by 2
Pharmacologic Treatment of Obesity
Nonas, C. (2006) · Topics in Clinical Nutrition · doi:10.1097/00008486-200601000-00003 · Cited by 2
Pliego-Reyes, C. L., Alcántar-Ramírez, J., Cárdenas-Cejudo, A., Díaz-Jiménez, K., Morales-Andrade, E., Ramírez-Wiella, G., Ríos-Martínez, B. P., Sánchez-Lío, K. I., Tenorio-Aguirre, K., & Torres-Viloria, A. (2015) · Medicina Interna de México · Cited by 1
Obesity Management and Prevention of Cardiovascular Disease
Gazda, C., & Almandoz, J. P. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56279-3_7 · Cited by 1
Medical Management of Obesity Associated with Mood Disorders
McElroy, S. L., Kotwal, R., & Keck, P. E. (2006) · CRC Press eBooks · doi:10.3109/9780849374517.016 · Cited by 1
Obesity as a Neurobiologic Disorder: A Heavyweight Contender
Chávez-Castillo, M., Durán, P., Garrido, B., Díaz, A., Escalona, D., & Cano, C. (2022) · Current Psychiatry Research and Reviews · doi:10.2174/2666082218666220527120848 · Cited by 2
Cichoń, K., Chyćko, M., CZARNOTA, J., Kromer, A., Zapała, M. A., Środoń, A., Wilk, J., Cholewa, M. M., Gawryś, A., & Łapaj, M. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.35.01.008 · Cited by 1
Obesity Management: Clinical Review and Update of the Pharmacologic Treatment Options.
Plodkowski, R. A., McGarvey, M. E., Reisinger‐Kindle, K., Kramer, B., Nelson, E. B., Lee, J., & Nguyen, Q. T. (2016) · Europe PMC (PubMed Central) · Cited by 1
Eating Disorders and Reproduction in Women
Bayramova, A. N. (2017) · Journal of Gynecology and Womens Health · doi:10.19080/jgwh.2017.04.555663 · Cited by 1
New technique of intragastric sleeve: viability and survival in a pig model
Ribeiro, M. S., Zorrón, R., SILVA, S. J. Q., CADENA, S. M. R., Antunes, F., dos Santos, M. B., Mello, L. D. M., IGREJA, H. J. S., Batista, V. L., Scheffer, J. P., et al. (2018) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201820180199 · Cited by 2
Use of Pharmacotherapy in Obesity Management
Tham, K. W. (2021) · The Singapore Family Physician · doi:10.33591/sfp.47.5.u6 · Cited by 1
Gautam, C., Sharma, J., Singla, M., Tiwana, I. K., & Singh, H. (2021) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2021.17.1.33 · Cited by 1
Obesity and Therapeutic Approaches to Weight Loss
Kushner, R. F. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-963-5_4 · Cited by 1
The use of very-low-calorie diets (VLCDs) and meal replacements for weight control
Anderson, J. W., & Konz, E. C. (2005) · Elsevier eBooks · doi:10.1533/9781845690540.3.379 · Cited by 2
Treatment Options: The Evidence for What Works
Pearson, D., & Grace, C. (2012) · Wiley eBooks · doi:10.1002/9781118702758.ch3 · Cited by 1
Orlistat Enhances The Hypocholesterolemic Effects Of An Energy-Restricted Diet
Anderson, J. W. (2007) · Future Lipidology · doi:10.2217/17460875.2.2.109 · Cited by 2
Andersen, T. (2003) · Obesity Reviews · doi:10.1046/j.1467-789x.2003.00097.x · Cited by 1
Garelli, S., Salituro, N., Pontesilli, G. M., Ricciardiello, L., Vicennati, V., & Pagotto, U. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65344-8 · Cited by 2
Weber, M. A. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3358-5.50044-9 · Cited by 1
Antidepressants for polycystic ovary syndrome
Zhuang, J., Wang, X., Xu, L., Wu, T., & Kang, D. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008575 · Cited by 2
Adjunctive Therapy, Including Pharmacotherapy
Al-Bazz, D. Y., & Wilding, J. P. H. (2022) · Wiley eBooks · doi:10.1002/9781119695257.ch21 · Cited by 1
Halford, J. C. G. (2013) · Springer eBooks · doi:10.1007/978-3-642-27772-6_110-2 · Cited by 2
Integrated Approach to Treatment and Prevention
Scheen, A. J. (2004) · CRC Press eBooks · doi:10.1201/9780203508756.ch23 · Cited by 1
Uchegbu, E. C., & Kopelman, P. G. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-375083-9.00214-2 · Cited by 1
Bioactive alginates and macronutrient digestion
Chater, P. I. (2014) · Cited by 1
Interventiestrategieën bij overgewicht
Mathus-Vliegen, E. M. H. (2004) · Bijblijven · doi:10.1007/bf03059809
Losing weight and keeping it off: workplace and dietitian clinic settings
Zinn, C. (2012) · Tuwhera (Auckland University of Technology) · Cited by 1
Obesity: The Elephant in the Room
Cooper, K., Schauer, P. R., Brethauer, S. A., & Kashyap, S. R. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1198-7_20
Antiobesity Pharmacotherapy: Current Treatment Options and Future Perspectives
Shi, Y. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn073
Harrell, T. K., Ross, L. A., & King, D. S. (2005) · Journal of Pharmacy Technology · doi:10.1177/875512250502100602
Pharmacotherapy of obesity in the near term
Penn, M., & GOLDSTEIN, D. J. (2003) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200310000-00001
[Consensus of diagnosis and treatment of obesity in women in reproductive age and climacterium].
Ortega-González, C., Aguilera-Pérez, J. R., Arce-Sánchez, L., Barquera-Cervera, S., Díaz-Polanco, A., Fernández-Sánchez, M., Ferreira‐Hermosillo, A., Martínez-Cruz, N., Medina-García, C., Ma, M.-A., et al. (2015) · PubMed · Cited by 2
Krotkiewski, M., & Janiak, R. (2008) · Endokrynologia, Otyłość i Zaburzenia Przemiany Materii · Cited by 1
Snow, V. T., Barry, P. P., Fitterman, N., Qaseem, A., & Weiss, K. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.06.023 · Cited by 3
Butle, S. R., Kulkarni, A., & Dighe, S. B. (2010)
Parents’ experiences of seeking health care for their children who are overweight or obese
Ahmed, B. (2010) · cIRcle (University of British Columbia) · doi:10.14288/1.0092544
Healthy Weight Maintenance: A Narrative Analysis of Weight Cycling in the Formerly Obese
Lewis, C. R. (2016) · ScholarWorks (Walden University)
Pharmacotherapeutic Options for the Treatment of Patients with Obesity
Debellis, L. R., & Wrobel, M. J. (2012) · Journal of Pharmacy Technology · doi:10.1177/875512251202800508
Kushner, R. F. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3291-5.50040-8
Treating the Morbidly Obese Patient: A Lifestyle Approach to a Chronic Condition
Taylor, J. E., Pyle, S. A., Poston, W. S. C., & Foreyt, J. P. (2005) · CRC Press eBooks · doi:10.3109/9780203025758-4
Self-citationPharmacologic Therapy for Obesity and Overweight in Adults and Adolescents
Aronne, L. J., & Thearle, M. S. (2006) · CRC series in modern nutrition science · doi:10.1201/9781420004649.ch6
Buranapin, S., & Apovian, C. M. (2006) · Fundamental and clinical cardiology · doi:10.3109/9781420018905.013 · Cited by 1
BARIATRIC SURGERY; RISK AND BENEFIT
Merdan, I. (2007) · Basrah Journal of Surgery · doi:10.33762/bsurg.2007.56197
Understanding and treating obesity in daily life: a cognitive behavioral perspective
Boh (2017) · Research Publications (Maastricht University) · doi:10.26481/dis.20170413bb
Neuropsychopharmacology of appetite in healthy volunteers
Thomas, J. M. (2015) · University of Birmingham Institutional Research Archive (University of Birmingham)
ANALES DE LA REAL ACADEMIA NACIONAL DE FARMACIA
Tamargo, J. L. (2016)
The Pathophysiology of Appetite Control
Blundell, J., & Halford, J. (2004) · CRC Press eBooks · doi:10.1201/9780203508756-10
Kanhere, H. A., & Trochsler, M. (2019) · Springer eBooks · doi:10.1007/978-3-319-92768-8_24
Weight Loss Medications in Adolescents
Buckley, L. L., Bessesen, D. H., & Zeitler, P. S. (2019) · Contemporary Endocrinology · doi:10.1007/978-3-030-25057-7_19
van den Akker, O. (2012) · doi:10.1002/9781119968382.ch5
State-of-the-Art Drug Therapies of Obesity
Antsiferov, M. B., Moscow, R. F., & Markova, T. N. (2021) · Doctor Ru · doi:10.31550/1727-2378-2021-20-2-45-50 · Cited by 2
Jacbs, R. S. W., & BILLING., G. C. (2018)
(2009) · Springer eBooks · doi:10.1007/978-3-211-69390-2_3
The Pathophysiology of Appetite Control
Blundell, J. E., & Halford, J. C. G. (2004) · CRC Press eBooks · doi:10.1201/9780203508756.ch2
Rangan, C. (2012) · Wiley eBooks · doi:10.1002/9781118105955.ch13
(2011) · CRC Press eBooks · doi:10.1201/b10790-15
Pharmacotherapy for Weight Loss
Lutz, T. A., & Asarian, L. (2017) · Routledge eBooks · doi:10.1201/9781315120171-14 · Cited by 1
Halford, J. C. G. (2010) · Springer eBooks · doi:10.1007/978-3-540-68706-1_110
(2011) · Elsevier eBooks · doi:10.1016/b978-0-7295-3804-6.50044-1
Brethauer, S. A., Kashyap, S. R., & Schauer, P. R. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6643-9.00058-8
The use of very-low-calorie diets (VLCDs) and meal replacers for weight control
Anderson, J., & Konz, E. C. (2010) · Woodhead Publishing Limited eBooks · doi:10.1533/9781845690840.3.379
Gautam, C., Sharma, J., Singla, M., Tiwana, I. K., & Singh, H. (2021) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2021.1.1.33
(2005) · BMJ · doi:10.1136/bmj.331.7529.1390-a
Halford, J. C. G. (2015) · Springer eBooks · doi:10.1007/978-3-642-36172-2_110
Ertürk, E., Ocak, K., Uyan, U., Çoner, A., Kocabaş, U., Kış, M., Başkurt, A. A., Oray, D., Sayın, B. Y., Mammadov, G., et al. (2023) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.2688
Use of Pharmacotherapy in Obesity Management
Wei, T. K. (2024) · The Singapore Family Physician · doi:10.33591/sfp.49.9.u5
Introduction to Obesity and Anti-obesity Medications
Garcha, S. C., & Kalra, S. (2025) · Springer eBooks · doi:10.1007/978-981-96-1651-0_1
Anti-Obesity Agents on the Horizon
Kim, S. H. (2025) · Korean Journal of Family Practice · doi:10.21215/kjfp.2025.15.1.2
Bioactive‐Based Nanocarriers for the Treatments of Obesity
Kaur, L., Singh, B., Tandon, R., Madaan, R., Sindhu, R. K., & Singh, S. (2025) · Wiley eBooks · doi:10.1002/9781394287345.ch21
Weight Loss Medications and the Metabolic Syndrome
Buckley, L. L., & Berressen, D. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-192-5_16
Farmacotherapie ter behandeling van obesitas
ZELISSEN, P. M. J. (2013) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-0508-7_44
Obesity medications and acquired hypothalamic obesity in adults: A two-case experience
Lang, H., Dorand, M. F., Hassan, M., & Richards, J. R. (2026) · Obesity Pillars · doi:10.1016/j.obpill.2026.100246
Anti-obesity Pharmacotherapy for Transplant Recipients
Haugen, C. E., & Orandi, B. J. (2026) · Current Atherosclerosis Reports · doi:10.1007/s11883-026-01388-1 · Cited by 1
Treatment of obesity: New drugs
Berti, S., Garelli, S., & Pagotto, U. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00330-7
The evolution of obesity pharmacotherapy from sympathomimetics to incretin-based therapies
Ncube, K. N., Moloi, N., & Malange, T. D. (2026) · SA pharmaceutical journal. · doi:10.36303/sapj.4108 · Cited by 1
Etude et caractérisation des vésicules extracellulaires dans un contexte d’obésité
Amosse, J. (2019) · theses.fr (ABES) · doi:10.70675/2d90fa73z378bz47bdza83cz809db70f24fb
Metadata
- Authors
- Haddock, C., Poston, W., Dill, P., Foreyt, J., & Ericsson, M.
- Affiliations
- Saint Luke's Hospital (US)
- University of Missouri–Kansas City (US)
- Venue
- International Journal of Obesity
- Published
- 2002-02
- Volume
- 26
- Issue
- 2
- Pages
- 262-273
- ISSN
- 0307-0565 (ISSN-L)
- 1476-5497
- OpenAlex
- W2069004141
- Cited by
- 303
- References
- 23
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 5 · 2023: 5 · 2022: 6 · 2021: 11 · 2020: 6 · 2019: 6 · 2018: 12 · 2017: 13 · 2016: 9 · 2015: 17 · 2014: 8 · 2013: 21 · 2012: 15
- FWCI
- 12.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- International Journal of Obesity (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Keywords
- obesity pharmacotherapy, anti-obesity drugs, weight loss, amphetamine, fenfluramine, sibutramine, benzphetamine, combination therapy, placebo effect, drug efficacy comparison, methodological factors
- MeSH terms
- Amphetamines, Benzphetamine, Cyclobutanes, Fenfluramine, Humans, Obesity, Randomized Controlled Trials as Topic, Anti-Obesity Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.